AzTrials
AzTrials

CaregiverNCT03867916

Patient Portal and Navigation Program in Providing Information for Asian American Cancer Patients

A study testing Patient Navigation Program, Quality-of-Life Assessment and Survey Administration in people with Caregiver and Malignant Neoplasm, run by University of California, San Francisco at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This phase I/II trial studies how well patient portal and navigation program work in providing information for Asian American cancer patients. Patient portal and navigation program may help to improve the care provided to Asian American cancer patients.This study is offered in the following languages in addition to… Read more about this study

Who is it for?
Ages 21 years and olderHealthy volunteers can take part
Conditions the study is for
Caregiver, Malignant Neoplasm, Physician
What is being tested?
Patient Navigation Program, Quality-of-Life Assessment and Survey Administration
Could I receive a placebo?
No, everyone receives an active treatment
How many people
106 participants
Where
1 siteUnited States
Study dates
13 Dec 2018to 31 Dec 2022
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 21 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • FOR INTERVIEWS AND FOCUS GROUPS:
  • Cancer patients: Self-identifies as Asian American, lives in San Francisco, speaks English, Mandarin, Cantonese, or Vietnamese, has a history of cancer of any kind
  • Caregivers: any person age 21 and older who has provided care to an Asian American cancer patient
  • Health professionals: physicians and other health professionals age 21 and older who provide care to Asian American patients with cancer
  • FOR PILOT IMPLEMENTATION:
  • Self-identifies as Asian American
Show all 20Show fewer
  • Ages 21 or older
  • Lives in the 9 counties of the greater bay area cancer registry (GBACR)
  • Speaks English, Mandarin, Cantonese, or Vietnamese
  • Has any stage colorectal, lung, or liver cancer
  • Has not started treatment or has not completed treatment
  • Is willing to stay in the study for six months.
  • FOR FULL IMPLEMENTATION:
  • Self-identifies as Asian American
  • Ages 21 or older
  • Lives in the 9 counties of the GBACR
  • Speaks English, Mandarin, Cantonese, or Vietnamese
  • Has any stage colorectal, lung, or liver cancer,
  • Has not started or has not completed treatment
  • Is willing to stay in the study for six-seven months

Who cannot join

  • Any medical or psychological conditions precluding informed consent

Trial locations and contacts

1 site in 1 country.

United States1 site
  • University of California, San Francisco

    San Francisco, California, 94158

Other trials in United States

About this study

Official title: The Patient Cancer OUtreach, Navigation, Technology, and Support (Patient COUNTS) Project: Addressing Care for Asian Americans With Cancer

This phase I/II trial studies how well patient portal and navigation program work in providing information for Asian American cancer patients. Patient portal and navigation program may help to improve the care provided to Asian American cancer patients.This study is offered in the following languages in addition to English: Chinese (Cantonese or Mandarin) and Vietnamese.

Read the detailed description

PRIMARY OBJECTIVES:

  1. Identify Asian American adults newly diagnosed with colorectal, liver, or lung cancer using a population-based cancer registry.

II. Conduct outreach to these patients to let them know about the availability of information on these cancers, the Patient Cancer OUtreach, Navigation, Technology and Support (COUNTS) web portal, and the Patient COUNTS patient navigation program.

III. Provide patient navigation either virtually or in-person.

OUTLINE:

Patients attend focus groups to help develop patient portal and navigation program. Patients use in-person navigation program. In phase II, patients use an online portal to access navigation program and may choose to have online/virtual navigation support or in-person navigation support. Patients also complete data collection and surveys over 15 minutes via web portal at baseline, 3 months, and 6 months and user experience survey at end of program participation.

Being tested
Patient Navigation Program, Quality-of-Life Assessment, Survey Administration
Medical subject headings
Neoplasms, Colorectal Neoplasms, Liver Neoplasms, Lung Neoplasms

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Patient Navigation ProgramBehavioural

    Also called Patient Navigator Program

    Use patient navigation program

  • Quality-of-Life AssessmentOther

    Also called Quality of Life Assessment

    Ancillary studies

  • Survey AdministrationOther

    Ancillary studies

Study groups in NCT03867916
Study groupRoleWhat they receive
Health services research (Patient COUNTS)ExperimentalPatients attend focus groups to help develop patient portal and navigation program. Patients use in-person navigation program. Patients also complete data collection and surveys over 15 minutes via web portal at baseline, 3 months, and 6 months and user experience survey at end of program participation.
Receives: Behavioral: Patient Navigation Program; Other: Quality-of-Life Assessment; Other: Survey Administration

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Rate of Participation

    At least one contact with patient navigator

    Measured: Any time between consent and month 6

Secondary outcomes (2)
  1. Adherence to Guideline Treatment

    Positive response(s) to survey item(s) on completion of MD-recommended treatment

    Measured: Month 6

  2. Patient Acceptability

    Response of "satisfied" or "very satisfied" to survey item on satisfaction with Patient COUNTS navigation program

    Measured: Month 7

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted8 Mar 2019
  2. Study start13 Dec 2018
  3. Primary completion30 Nov 2022
  4. Study completion31 Dec 2022

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Health services research
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
106 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03867916
Sponsor's protocol ID
184511
Other IDs
NCI-2018-02196
Status last verified
Jan 2023
First submitted
6 Mar 2019
Last updated
12 Jan 2023
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Wang K, Chu JN, Oh DL, Shariff-Marco S, Allen L, Kuo MC, Wong C, Bui H, Chen J, Li FM, Ma C, Truong A, Gomez SL, Nguyen TT, Tsoh JY. Correlates of supportive care needs among Asian Americans with colorectal, liver, or lung cancer from a web-based patient navigation portal intervention: The Patient COUNTS study. Cancer Rep (Hoboken). 2024 Feb;7(2):e1971. doi: 10.1002/cnr2.1971.

    PubMed 38351528
  • Wang K, Ma C, Li FM, Truong A, Shariff-Marco S, Chu JN, Oh DL, Allen L, Kuo MC, Wong C, Bui H, Chen J, Gomez SL, Nguyen TT, Tsoh JY. Patient-reported supportive care needs among Asian American cancer patients. Support Care Cancer. 2022 Nov;30(11):9163-9170. doi: 10.1007/s00520-022-07338-2. Epub 2022 Aug 30.

    PubMed 36040670

Questions about this trial

What is this clinical trial studying?

A study testing Patient Navigation Program, Quality-of-Life Assessment and Survey Administration in people with Caregiver and Malignant Neoplasm, run by University of California, San Francisco at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 20 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 12 Jan 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Rate of Participation (time frame: Any time between consent and month 6). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT03867916, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 12 Jan 2023.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in